Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Work In Process (2022 - 2025)

Historic Work In Process for Fortress Biotech (FBIO) over the last 4 years, with Q1 2025 value amounting to $435000.0.

  • Fortress Biotech's Work In Process fell 4596.27% to $435000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $435000.0, marking a year-over-year decrease of 4596.27%. This contributed to the annual value of $367000.0 for FY2024, which is 5848.42% down from last year.
  • Latest data reveals that Fortress Biotech reported Work In Process of $435000.0 as of Q1 2025, which was down 4596.27% from $367000.0 recorded in Q4 2024.
  • Over the past 5 years, Fortress Biotech's Work In Process peaked at $2.7 million during Q2 2022, and registered a low of $26000.0 during Q3 2022.
  • Its 4-year average for Work In Process is $707416.7, with a median of $495500.0 in 2022.
  • As far as peak fluctuations go, Fortress Biotech's Work In Process skyrocketed by 166153.85% in 2023, and later crashed by 7019.13% in 2024.
  • Fortress Biotech's Work In Process (Quarter) stood at $395000.0 in 2022, then soared by 123.8% to $884000.0 in 2023, then plummeted by 58.48% to $367000.0 in 2024, then rose by 18.53% to $435000.0 in 2025.
  • Its Work In Process stands at $435000.0 for Q1 2025, versus $367000.0 for Q4 2024 and $296000.0 for Q2 2024.